Grantham, Mayo, Van Otterloo & Co (GMO)
CLGX

Grantham, Mayo, Van Otterloo & Co (GMO)’s Corelogic, Inc. CLGX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CLGX Stock Details CLGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,868
Closed -$307K – 897
2021
Q1 		$307K Sell
3,868
-35,577
-90% -$2.84M ﹤0.01% 780
2020
Q4 		$3.05M Buy
39,445
+26,200
+198% +$1.96M 0.02% 373
2020
Q3 		$896K Buy
+13,245
New +$891K 0.01% 541
2019
Q2 		– Sell
-14,100
Closed -$525K – 793
2019
Q1 		$525K Buy
+14,100
New +$520K ﹤0.01% 576

Grantham, Mayo, Van Otterloo & Co (GMO)'s CLGX Position: Q2 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Corelogic, Inc. (CLGX) in Q2 2021, closing a stake of 3,868 shares — an estimated $307K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CLGX in Q1 2019 and held it in 4 quarters. The position peaked at $3.05M in Q4 2020. 0 funds tracked by Wall St. Rank hold CLGX as of Q2 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Corelogic, Inc. position as of Q2 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 3,868 Corelogic, Inc. shares in Q2 2021, an estimated $307K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Corelogic, Inc. in Q1 2019 and held it in 4 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Corelogic, Inc. position peaked at $3.05M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Corelogic, Inc. as of Q2 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2021, filed 12 Aug 2021.